Evidence map›Paper›PMID 8675078›Full record

ArticleGut1996

Why is epidermal growth factor present in the gut lumen?

R J Playford, N A Wright

Open access · bronzeAbstract read
In one paragraph

Article in Gut, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 106 citations in OpenAlex.

  1. Trial
  2. Review
  3. Physiological effects ofFrontiers in veterinary science · 2023
    Review
  4. Article
  5. Article
  6. Distribution of bioactive factors in human milk samples.International breastfeeding journal · 2019
    Article
  7. Crystal structure and mechanism of human carboxypeptidase O: Insights into its specific activity for acidic residues.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Amniotic fluid: Source of trophic factors for the developing intestine.World journal of gastrointestinal pathophysiology · 2016
    Review
  15. Pathogenesis of neonatal necrotizing enterocolitis.Pediatric surgery international · 2015
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

R J PlayfordDepartment of Gastroenterology, Leicester General Hospital.
N A Wright
Leicester General Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The jury is still out on the role of luminal EGF in the normal gastrointestinal tract. Recent evidence, however, suggests that its major function is to act as a 'luminal surveillance' peptide, which is available to stimulate repair and that it is not of major importance in maintaining normal gut growth. Recombinant EGF administered via the gut lumen could still prove a valuable tool for the treatment of gastrointestinal ulceration. Perhaps the old term for EGF, 'epidermal healing factor' or EHF, was more appropriate after all!

Indexed as

Intestinal MucosaIntestinesAnimalsCell DivisionEpidermal Growth FactorErbB ReceptorsHumansIntestinal DiseasesMiceMice, KnockoutRatsRecombinant ProteinsEpidermal Growth FactorErbB ReceptorsRecombinant Proteins

Identifiers

PMID8675078
PMCPMC1383054
OpenAlexW2040200458

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.